Led · Equity · Jul 2026

Smash Foods develops chia-fortified fruit spreads sweetened with dates rather than added sugar and produces nut-butter snacks called Jammy Protein Bites (and forthcoming Mini Bites) that incorporate its fruit spreads. The brand sources much of its fruit from upcycled sources and develops all products in-house, with classic flavors like Strawberry, Concord Grape, Apricot and Raspberry and an eighth flavor, Fig, planned. Smash’s Jammy Protein Bites launched in 2024 and expanded the business from a jam-focused company into a snacking brand with national distribution in Whole Foods, Costco, Target and roughly half of Walmart locations. The company reports it has surpassed 10,000 doors nationwide, more than tripled its business year-over-year and reached profitability. Management plans to use the new capital to build manufacturing capabilities with meticulous specifications for the Bites and Mini Bites and to invest in brand development and go-to-market scale.

Participated · Series D · Jul 2026

Genius AI (formerly GlossGenius) is a New York-based technology platform for in-person service businesses, building software that automates the administrative work of running a business. Its flagship product, GlossGenius, handles booking, payments, marketing, staff management and client management for salons, spas and studios, and includes branded card-reader hardware alongside back-office tools for bookkeeping, inventory and expenses. The platform serves more than 125,000 service businesses across roughly half of all US ZIP codes. Following a July 2026 rebrand from GlossGenius, the company is extending beyond beauty and wellness into the wider in-person service economy, including health, with agentic AI products intended to run end-to-end workflows autonomously. Genius AI is approaching a $200 million annual revenue run rate and is headquartered in New York. Financially, the company states it has raised more than $125 million to date, most recently a $44 million Series D at a $1.15 billion valuation led by Lux Capital.

Participated · Equity · Jul 2026

Hemispheric developed Descartes, a 6-billion-parameter NeuroAI foundation model trained on a proprietary multimodal EEG and behavioral dataset of more than 250,000 hours from over 100,000 participants. Descartes is designed to translate brain electrical activity into objective measures that can detect disease earlier, distinguish disorder subtypes, and guide treatment selection. The company deploys a lightweight dry EEG headset worn for about 15 minutes while users interact with an app to capture brain activity without surgery or lengthy protocols. Hemispheric has built dedicated data-collection labs and model-training infrastructure and demonstrated its platform to the FDA's Center for Devices and Radiological Health while pursuing a broad regulatory strategy. Its initial clinical applications target conditions including PTSD, mTBI, depression, anxiety, schizophrenia, and Alzheimer’s disease. The company has a 112-person interdisciplinary team and announced a $52 million early-stage financing to accelerate deployment, grow its data network, and advance regulatory and commercial efforts.

Led · Series A · Jun 2026

Founded in 2024 by board-certified dermatologist Dr. Muneeb Shah, REMEDY (also referred to as Remedy Science) formulates clinically informed skincare solutions addressing concerns such as dark spots, dryness, fine lines, dullness, keratosis pilaris, and sensitive skin. The brand emphasizes formulations that mirror a dermatologist’s clinical approach—starting with patient concerns and prioritizing visible results without compromising skin health. Since launch, REMEDY has achieved rapid commercial growth across DTC, Amazon, and TikTok Shop and has earned recognition as a Beauty Matter 2026 FUTURE50 brand and as a TikTok-favorite dermatologist label. Financially, the company secured a $20 million oversubscribed Series A minority investment led by L Catterton with participation from Norwest Venture Partners and Sonoma Brands Capital. REMEDY intends to use the proceeds for clinical research, product innovation, team expansion, and continued retail and e-commerce expansion.

Participated · Series B · Jun 2026

California Naturals, founded in 2023 by Shelby Wild, is a natural-beauty brand. The company is pursuing retail expansion into national chains including Target, Ulta, and CVS and plans new category launches. Leadership is shifting as COO Hayden Hiatt—who previously held multiple leadership roles at Glossier—moves into the CEO role while founder Shelby Wild remains involved. Financially, the brand reported finishing the year 220% above its 2023 sales forecast and is projecting 800% year-over-year revenue growth. The company has raised more than $40 million across three funding rounds to date, including the recently closed Series B led by Align Ventures with participation from Elizabeth Street Ventures.